Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Gastonia › NPI 1700213956
Physician

Caromont Medical Group INC

Caromont Medical Group INC was paid $761K by Medicaid between Jan 2018 and Dec 2024, across 12 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 52% of everything it billed.

33Billing provider infoCAROMONT MEDICAL GROUP INC
GASTONIA, NC 28054
33aNPI1700213956assigned 10/02/2013
28Total paid$761K
24GClaims20,811
24DCodes billed12
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Family Medicine Physician providers in North Carolina

Rank by total paid#176 of 960
Median peer was paid$135K
This provider vs. median5.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official OCONNOR, DAVID controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,839$76K
20191,526$76K
2020942$44K
2021719$36K
20223,746$119K
20236,447$211K
2024incomplete5,592$199K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 52% 9,211 7,349 $398K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 24% 2,734 2,133 $185K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 11% 2,295 1,638 $82K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 4.9% 3,552 1,631 $37K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2.9% 285 271 $22K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2.8% 1,954 1,581 $21K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 1.8% 411 387 $14K
71046 Radiologic examination, chest; 2 views <1% 78 75 $1K
87807 <1% 65 28 $483.22
81003 <1% 29 26 $44.76
3078F 0% 104 78 $0.00
3074F 0% 93 67 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialOCONNOR, DAVID (CFO)
Parent organizationCAROMONT MEDICAL GROUP INC
Same official

Other billing entities under OCONNOR, DAVID

Full network →
ProviderLocationPaid
Caromont Medical Group INCBelmont, NC$3.81M
Caromont Medical Group, INC.Gastonia, NC$2.77M
Caromont Medical Group, INC.Gastonia, NC$2.41M
Caromont Medical Group, INC.Dallas, NC$1.79M
Caromont Medical Group, INC.Gastonia, NC$1.72M
Mass Surgical Supply, LLCHolyoke, MA$1.59M
Caromont Medical Group INCGastonia, NC$1.37M
Caromont Medical Group INCGastonia, NC$1.20M
Caromont Medical Group INCGastonia, NC$1.19M
Caromont Medical Group INCGastonia, NC$1.07M
Caromont Medical Group, INC.Belmont, NC$1.07M
Caromont Medical Group INCGastonia, NC$911K
Caromont Medical Group INCCherryville, NC$842K
Caromont Medical Group INCMcadenville, NC$629K
Caromont Medical Group INCShelby, NC$621K
Caromont Medical Group INCGastonia, NC$619K
Caromont Medical Group, INC.Belmont, NC$592K
Caromont Medical Group INCGastonia, NC$590K
Caromont Medical Group, INC.Dallas, NC$540K
Caromont Medical Group INCBelmont, NC$489K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.